General Information of DTT (ID: TTP9K3Q)

DTT Name SOD1 messenger RNA (SOD1 mRNA) DTT Info
Gene Name SOD1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tofersen DM0AEDT Amyotrophic lateral sclerosis 8B60.0 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-SOD1 DMV1BTP Amyotrophic lateral sclerosis 8B60.0 Phase 1 [2]
------------------------------------------------------------------------------------
7 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS 150450 DMMBW13 Discovery agent N.A. Investigative [3]
ISIS 150451 DM1DCFP Discovery agent N.A. Investigative [3]
ISIS 150452 DMQE7BH Discovery agent N.A. Investigative [3]
ISIS 150453 DMKCG41 Discovery agent N.A. Investigative [3]
ISIS 150454 DMW0Y75 Discovery agent N.A. Investigative [3]
ISIS 150463 DMFUM62 Discovery agent N.A. Investigative [3]
ISIS 150464 DM1IC54 Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
3 US patent application no. 7,132,530, Antisense modulation of superoxide dismutase 1, soluble expression.